28th International Conference on Cancer Research and Pharmacology

Cancer Research 2020 will enlighten the public with recent advances in Cancer diagnosis, Cancer therapy and Pharmacology around the world and to sharpen the related ideas about Cancer Research. Moreover, Cancer Research 2020 provides you a great networking with peers. World-renowned speakers, the most recent techniques, and the newest updates in cancer research fields are the trademark of this conference. Cancer conferences, symposiums, and Workshops provide a dedicated forum for the advancement, execution, and exchange of information about Oncology and Cancer. Cancer Research 2020 is an extraordinary event designed for International medical health professionals, Pharmacologists and oncologists to facilitate the dissemination and application of research findings related to Cancer. The Cancer Research Conference invites participants from all leading universities, clinical research institutions, and diagnostic companies to share their research experiences on all aspects of this rapidly expanding field and thereby, providing a showcase of the latest techniques. Cancer Research 2020 provides an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking. The main aim of this conference is to provide Informative Sessions on Cancer and Pharmacology Research: Challenges and Achievements.

Theme: Conquering Cancer with the Modern progression

Conference Website: https://cancer.cmesociety.com/

Important Conference Highlights:
Radiation Oncology
Neuro-Oncology
Cancer Imaging and Early Detection
Cancer Screening and Diagnosis
Biology of Pediatric and Young Adult Cancer
Radiology and Imaging Technologies
Cancer Nanotechnology
Oncology Nursing Care
Cancer Nanomedicine
Cancer Prevention Vaccines
Advances in Pharmacological Research
Therapeutic Innovation in Pharmacology
Pediatrics Pharmacology

Past Conference Speaker Highlights (Cancer Research 2019):

Keynote talk:
Title: Noninvasive risk stratification of patients using predictive biomarker apoptosis index of tumors
Raghu Pandurangi, Sci-Engi-Medco Solutions Inc. and Amplexi-LLC, USA
Title: Hydrogen peroxide inducible clone-5 mediates positive feedback ROS-JNK-c-jun signaling for HCC progression
Wen-Sheng Wu,Tzu Chi University, Taiwan
Title: Role of biochemistry in industrial waste water treatment processes
Mukesh Pandya, Jaihind College, India
Title: In silico modeling of Bcr-Abl oncoprotein isoforms in chronic myelogenous leukemia
Entissar S AlSuhaibani, King Saud University, KSA
Session Speakers:
Title: Real-time potentiometric monitoring hydrolysis of a bio-degradable drug (Atracurium besylate)
Ahmed Ma'mun, Cairo University, Egypt
Title: Intestinal microorganisms and colorectal cancer: Causative or opportunistic agents Chandramathi S, University of Malaya, Malaysia
Title: Targeting Axl/EZH/Sox2 for glioblastoma multiform by novel biodegradable interstitial delivery system
Horng-Jyh Harn, Buddhist Tzu Chi Medical Foundation, Taiwan
Title: Chitinase production from Paenibacillus sp. BISR-047 utilizing seafood waste as substrate under solid-state fermentation
Saavi Pradhan, Banasthali University, India
Title: Comparative study on how low cost in clinic activities increases patient satisfaction during waiting time at OPD in selected oncology center
Saurav Bhowmik, D Y Patil University, India
Title: Bioinsilico analysis of c-MYC gene association with Burkitt's Lymphoma
Enas Abdalla Mohammed Ahmedon, University of Khartoum, Sudan

Our targeted Audience:
Oncologists, Pharmacologists, Pharma Practitioners, Radiologists, Chemotherapists, Physicians, Academicians, Academic scientists, Industry professionals, Diagnostic laboratory professionals, Undergraduate & Postgraduate students, researchers, business professionals, Postdoctoral fellows and Trainees, Cancer Diagnostics Associations and Societies

Exhibitor:
The 28th International Conference on Cancer Research and Pharmacology will exhibit the products and services from commercial and non-commercial organizations like Drug manufactures, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

Benefits:
Best platform to develop new partnership & collaborations.
Best location to speed up your route into every territory in the World.
89% our conference attendees are the Key contact in their labs purchasing decisions.
Our exhibitor booths were visited 4-5 times by 80% of the attendees during the conference.
Past exhibitor's feedback reveals ample of enquiries perceived from the conference attendees.
Network development with both Academia and Business.
1 page publication of the exhibitor profile in the souvenir- Cancer Research 2020.
Promotion through the conference website.
Promotional video on company products during the conference.
Logo recognition in the Scientific program, Conference banner and flyer.

Collaborators:
Cancer Research 2020 is collaborated with Eureka Science. Eureka Science was established in 2008 with an objective to become a pioneer in providing superior quality services to all the publishers and organizations around the globe. The expertise and responsiveness of our support team are vital to our success. The company has evolved with a scope to stand and compete with the major international multimedia publishing companies in catering a variety of services to professional science and healthcare communities worldwide.

For Conference Program and Media Partners Contact:
Ethan Connor
Program Manager
Mail: cancerresearch@pulsusseries.com

For general Queries:
Ethan Connor
Program Manager
Mail: cancerresearch@pulsusglobal.com
Sponsors / Exhibiting / Advertising / Collaboration:
cancerresearch@pulsusseries.com

35 Ruddlesway, Windsor, Berkshire, SL4 5SF, UK

Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.

With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of Paediatrics Intensive and Critical Care Societies, World Association of Medical Sciences, International Society for Ceramics in Medicine, Thalassaemia International Federation and World Association of Integrated Medicine to nurture the research and development for the beneficence of society.

Since many years Pulsus has also been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international conferences and meetings.

This release was published on openPR.